Effects of NS1608, a BK(Ca) channel agonist, on the contractility of guinea-pig urinary bladder in vitro.
1. The functional effects of NS1608 ((N-(3-(trifluoromethyl)phenyl)-N'-(2-hydroxy-5-chlorophenyl)urea), an opener of the large conductance, Ca2+-activated K+ (BK(Ca)) channel, on the contractility of guinea-pig urinary bladder muscle are described. 2. NS1608 (0.3-30 microM) had no significant effect on the integrated myogenic activity (tension integral) or the electrically evoked twitches of detrusor muscle strips. Possible mechanisms for the discrepancy between the lack of functional effects of NS1608 per se on detrusor contractility and this drug's agonistic effect on BK(Ca) currents in isolated bladder myocytes are discussed. 3. 4-Aminopyridine (1 mM), a blocker of voltage-gated K+ (K(V)) channels, increased the tension integral 2.7-fold, on average. NS1608 (30 microM) counteracted this effect. 4. Apamin (100 nM), a selective blocker of the small conductance, Ca2+-activated K+ (SK(Ca)) channel, increased the tension integral 1.7-fold, on average. This effect was reversed by NS1608 (30 microM). 5. Ryanodine (10 microM), a modulator of the sarcoplasmic reticulum (SR) Ca2+-release channel, increased the tension integral 1.9-fold, on average. This effect was reversed by NS1608 (30 microM). 6. Iberiotoxin (IbTX, 50 nM), a selective blocker of the BK(Ca) channel, caused additional increases in the tension integral of detrusor strips pretreated with apamin or ryanodine and prevented the inhibitory effects of NS1608 (30 microM) in detrusor contractility. 7. The present study shows that blockade of repolarizing currents carried by, respectively apamin- and 4-aminopyridine-sensitive K+ channels unmasks an activation of BK(Ca) in guinea-pig urinary bladder smooth muscle strips.
Mora
Ticiana Camila
TC
Divisão de Farmacologia, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Rua André Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil.
Suarez-Kurtz
Guilherme
G
D015761:4-Aminopyridine / Q000494:pharmacology; D000818:Animals; D001030:Apamin / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects* / Q000502:physiology; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D010455:Peptides / Q000494:pharmacology; D010671:Phenylurea Compounds / Q000494:pharmacology*; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024681:Potassium Channels, Calcium-Activated / Q000819:agonists* / Q000037:antagonists & inhibitors; D012433:Ryanodine / Q000494:pharmacology; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology
D010455:Peptides; D010671:Phenylurea Compounds; D026902:Potassium Channel Blockers; D024681:Potassium Channels, Calcium-Activated; D012433:Ryanodine; C103727:NS 1608; D001030:Apamin; C064719:iberiotoxin; D015761:4-Aminopyridine